About

Julie Plyler counsels clients primarily on capital markets and securities matters, with particular experience in the life sciences and financial services industries.

Julie represents clients…

Julie Plyler counsels clients primarily on capital markets and securities matters, with particular experience in the life sciences and financial services industries.

Julie represents clients in a variety of transactions, including initial public offerings, other primary and secondary registered offerings, and private placements (including in connection with reverse mergers). She also represents companies in connection with M&A and financing transactions. Julie advises public company clients across industries in the preparation of SEC periodic reports and proxy statements, Section 16 reporting, securities compliance matters and corporate governance matters.

Julie’s recent pro bono work includes representing charitable organizations in connection with corporate formation and governance matters.

Latest Post

With innovation comes regulatory scrutiny. On December 9, 2025, the Financial Industry Regulatory Authority, Inc. (“FINRA”) released its 2026 Annual Regulatory Oversight Report (the “2026 Report”), which includes a new section dedicated to generative artificial intelligence (“GenAI”). The 2026 Report is the latest iteration of FINRA’s yearly summary of insights from its regulatory oversight activities

About

Julie Plyler counsels clients primarily on capital markets and securities matters, with particular experience in the life sciences and financial services industries.

Julie represents clients…

Julie Plyler counsels clients primarily on capital markets and securities matters, with particular experience in the life sciences and financial services industries.

Julie represents clients in a variety of transactions, including initial public offerings, other primary and secondary registered offerings, and private placements (including in connection with reverse mergers). She also represents companies in connection with M&A and financing transactions. Julie advises public company clients across industries in the preparation of SEC periodic reports and proxy statements, Section 16 reporting, securities compliance matters and corporate governance matters.

Julie’s recent pro bono work includes representing charitable organizations in connection with corporate formation and governance matters.

Subscribe: Subscribe via RSS